Round Table | HI-NL

We are excited to be part of a Round Table session hosted by Health Innovation Netherlands (HI-NL), focused on innovation in the field of cancer diagnostics.

At the heart of this session is TzuPlus: our workflow for capturing circulating tumor cells (CTCs), molecularly characterizing those cells (DNA, RNA, proteins), and translating these findings into precision therapy. TzuPlus is the foundation for developing improved, next-generation cancer therapies tailored to inhibit the metastatic spread of cancer cells.

The HI-NL Track is proudly supported by a Health Holland SME grant, and the Round Table marks a key milestone on that journey.

Next
Next

Update | Processing our first blood samples